Intronix Technologies Blog

Myoguide Achieves TüV Certification Mark

By Evan Friedman | January 17, 2011

We are pleased to announce that we have received our TüV certification mark for Myoguide. Intronix Technologies’ commitment to quality assurance continues. Intronix worked with TüV SUD to certify compliance to all the IEC requirements to ensure safety for Myoguide.

MEDICA 2011

By Evan Friedman | January 12, 2011

Intronix will be returning to MEDICA, with Myoguide, in Düsseldorf, Germany: Hall 16, November 16-19, 2011. We are proud to have been selected to exhibit within the CANADA Pavilion, for the third time.

Intronix working with The Alfred Mann Foundation

By Evan Friedman | December 1, 2010

We are very pleased to be providing the Myoguide needle EMG guided injection system to the Alfred Mann Foundation for one of their research projects. The Foundation and its scientists have a track record of bringing innovative technical solutions to improve the life of persons suffering from debilitating medical impairments. We were very happy to…

MEDICA 2010

By Evan Friedman | November 25, 2010

Medica 2010 was a fantastic opportunity to catch up with old friends, contacts, and build important relationships through meetings. We are grateful to the Canadian Ministry of Economic Development and Trade (EDT), and Messe Düsseldorf (Canada) for their support during Medica. It was an extremely productive exhibition. We had several important meetings with European, Asian,…

Myoguide Needle EMG-guided Injection System Satisfies IEC/TUV Testing

By Evan Friedman | October 31, 2010

31/10/2010 Intronix Technologies Corporation Toronto, Ontario, October 31 2010 – Intronix Technologies has just had an IEC/TUV testing program completed on Myoguide, needle EMG guided injection system. Testing to TUV (c-us) mark to IEC/CSA/UL/60601-1, IEC 60601-1-2 – EMC standards, and IEC 60601-2-40 – “EMG” standards, has been completed, including a successful on-site inspection. Intronix Technologies…

Myoguide Needle EMG-guided Injection System at MEDICA 2010

By Evan Friedman | October 31, 2010

31/10/2010Intronix Technologies Corporation Toronto, Ontario, October 31, 2010 – Intronix Technologies Corporation will show their “new and improved” needle EMG (electromyography) guided injection system, Myoguide, at MEDICA 2010, November 17-20, in Düsseldorf, Germany. The updated Myoguide release complements the launch of Myoguide DOC. Myoguide DOC, is our new “tablet friendly” injection documentation software package. Myoguide…

Funny story from the AANEM 2010

By Evan Friedman | October 23, 2010

Funny Stories at Exhibitions, or Tales from the Great Beyond There are always collections of stories coming from conferences and exhibitions we attend. This tale comes from the AANEM 2010 meeting: Food was served in the exhibit hall, which probably is not too good an idea, other than the attendees will be there to enjoy…

AANEM Conference

By Evan Friedman | October 11, 2010

Intronix interacted with many of the clinicians and exhibitors attending the American Association of Neuromuscular and Electrodiagnostic Medicine Conference. Myoguide was well accepted and we were fortunate enough to be able to discuss many possibilities for cooperative projects. We are looking forward to following up many leads and inquiries. Our newest version of Myoguide includes…

Practical Pain Management Journal Citing September 8, 2010

By Evan Friedman | September 11, 2010

Myoguide has been cited in Practical Pain Management Journal, in the September 8, 2010 issue. The article addresses platelet rich plasma prolotherapy. This is where PRP is injected in into damaged tissue that had led an area into pain, discomfort, and reduced use. Myoguide was cited as a means to manage pain in these cases,…

Myoguide Guidance for Botulinum Toxin Injections

By Dr. Evan Friedman | August 23, 2010

PRESS: MYOGUIDE GUIDANCE FOR BOTULINUM TOXIN INJECTIONS Myoguide presents a comprehensive integrated system that was developed to better satisfy the needs of leading Neurologists, Physiatrists and clinicians injecting neuromodulators such as: Botox©, Myobloc©, Dysport©, and Xeomin© for the management of pain, movement disorders, and spastic muscle Date Released: 08/22/2010 Therapy with botulinum toxin should be…